Researchers created a highly efficient gene-editing method that fixes multiple DNA mutations in a single step. The breakthrough could revolutionize genetic medicine by making treatments for complex ...

The gene editing market is experiencing significant growth, with a projected annual growth rate (CAGR) of 16-18% in the coming years. This expansion is fueled by breakthroughs in gene-editing ...

Keith Speights has positions in Amazon, MercadoLibre, and Vertex Pharmaceuticals. The Motley Fool has positions in and recommends Amazon, MercadoLibre, TransMedics Group, and Vertex Pharmaceuticals.

New research out of the University of Iowa is reshaping what it means to live with cystic fibrosis, a genetic disease that ...

News from Wellington Airport A forest of 65 Christmas trees has sprouted at Wellington Airport, transforming the terminal in ...

Non-Cystic Fibrosis Bronchiectasis Treatment Market to Reach USD 3.5 Bn by 2035 at 5.8% CAGR, Driven by rising disease burden ...

For many families, Thanksgiving starts with turkey and tradition. The annual Turkey Trot drew several hundred participants on ...

On Wednesday, providers from Highland Hospital made another donation to support global efforts to treat cystic fibrosis. Cystic fibrosis is a genetic condition that causes ...

From 2008 to 2023, there has been a significant decrease in cystic fibrosis mortality rates and a significant rise in sickle ...

Live webcasts of the presentations will be available under the “Events” page within the Investors section of Sionna’s website at https://investors.sionnatx.com/. Replays will also be available ...

A UC Berkeley biochemistry PhD and gene editing expert has launched a new effort in the field of genetic engineering on human embryos as a way to prevent disease before birth.